Daymark Wealth Partners, LLC Fibrogen Inc Transaction History
Daymark Wealth Partners, LLC
- $2.71 Billion
- Q2 2024
A detailed history of Daymark Wealth Partners, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Daymark Wealth Partners, LLC holds 14,900 shares of FGEN stock, worth $5,811. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,900
Previous 14,900
-0.0%
Holding current value
$5,811
Previous $35,000
62.86%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FGEN
# of Institutions
115Shares Held
57.5MCall Options Held
2.14MPut Options Held
907K-
Primecap Management CO Pasadena, CA13.7MShares$5.33 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY8.94MShares$3.49 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$2.3 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.36MShares$1.31 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$939,7630.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $36.6M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...